Literature DB >> 20542730

The translatability of animal models for clinical development: biomarkers and disease models.

Alexandra Wendler1, Martin Wehling.   

Abstract

Translational science in medicine describes the transfer of basic in vitro and in vivo research into human applications. Animal models are important tools in translational science, and several different approaches such as genetically engineered animals, xenograft models, inbred strains and disease induction models are available for many diseases. Biomarkers are defined as any measurable parameters of biological processes. This includes disease pathophysiology and the impact of interventions thereon. Biomarkers represent the most important tool of translational science in medicine. Therefore, the development of biomarkers, which are useful and accessible both in animals and in humans, represents an important focus of translational activities. Imaging, for example, is translationally ideal as the readouts in disease models and patients are the same or at least very similar. Despite several approved animal models, the majority of compounds tested successfully in animals still fail to be successfully applied to human diseases. To reduce this rate of failure, animal models better resembling the human situation are needed. A new scoring system for the assessment of translatability is discussed; it facilitates the judgement on the predictivity of results from a given animal model regarding human translation by the weighed answers to important data features. These include robust animal data in more than one species, related human data and accessibility.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542730     DOI: 10.1016/j.coph.2010.05.009

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  25 in total

1.  Noise-induced cochlear synaptopathy in rhesus monkeys (Macaca mulatta).

Authors:  M D Valero; J A Burton; S N Hauser; T A Hackett; R Ramachandran; M C Liberman
Journal:  Hear Res       Date:  2017-07-08       Impact factor: 3.208

Review 2.  Nonhuman primate models in the genomic era: a paradigm shift.

Authors:  Eric J Vallender; Gregory M Miller
Journal:  ILAR J       Date:  2013

3.  The reductionist paradox: are the laws of chemistry and physics sufficient for the discovery of new drugs?

Authors:  Gerald M Maggiora
Journal:  J Comput Aided Mol Des       Date:  2011-06-23       Impact factor: 3.686

Review 4.  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.

Authors:  David Cook; Dearg Brown; Robert Alexander; Ruth March; Paul Morgan; Gemma Satterthwaite; Menelas N Pangalos
Journal:  Nat Rev Drug Discov       Date:  2014-05-16       Impact factor: 84.694

Review 5.  Mitigating risk in academic preclinical drug discovery.

Authors:  Jayme L Dahlin; James Inglese; Michael A Walters
Journal:  Nat Rev Drug Discov       Date:  2015-04       Impact factor: 84.694

Review 6.  Post-traumatic osteoarthritis of the ankle: A distinct clinical entity requiring new research approaches.

Authors:  Michelle L Delco; John G Kennedy; Lawrence J Bonassar; Lisa A Fortier
Journal:  J Orthop Res       Date:  2016-11-08       Impact factor: 3.494

7.  Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.

Authors:  Abhinav Srinath; Ying Li; Romuald Girard; Issam A Awad; Sharbel G Romanos; Bingqing Xie; Chang Chen; Yan Li; Thomas Moore; Dehua Bi; Je Yeong Sone; Rhonda Lightle; Nick Hobson; Dongdong Zhang; Janne Koskimäki; Le Shen; Sara McCurdy; Catherine Chinhchu Lai; Agnieszka Stadnik; Kristina Piedad; Julián Carrión-Penagos; Abdallah Shkoukani; Daniel Snellings; Robert Shenkar; Dinanath Sulakhe; Yuan Ji; Miguel A Lopez-Ramirez; Mark L Kahn; Douglas A Marchuk; Mark H Ginsberg
Journal:  Transl Stroke Res       Date:  2022-06-17       Impact factor: 6.829

Review 8.  Post-traumatic osteoarthritis: from mouse models to clinical trials.

Authors:  Christopher B Little; David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2013-05-21       Impact factor: 20.543

Review 9.  Modeling, simulation, and translation framework for the preclinical development of monoclonal antibodies.

Authors:  Kenneth T Luu; Eugenia Kraynov; Bing Kuang; Paolo Vicini; Wei-Zhu Zhong
Journal:  AAPS J       Date:  2013-02-14       Impact factor: 4.009

10.  Optimization of histologic grading schemes in spontaneous and surgically-induced murine models of osteoarthritis.

Authors:  A R Armstrong; C S Carlson; A K Rendahl; R F Loeser
Journal:  Osteoarthritis Cartilage       Date:  2021-02-06       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.